177 related articles for article (PubMed ID: 4401360)
1. Role of immunologic disturbance in human oncogenesis: some facts and fancies.
Kaplan HS
Br J Cancer; 1971 Dec; 25(4):620-34. PubMed ID: 4401360
[TBL] [Abstract][Full Text] [Related]
2. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
Miller RW
Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377
[No Abstract] [Full Text] [Related]
3. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
4. Proceedings: Immunological depletion contributing to familial Hodgkin's disease.
Fenelly JJ; McBride A
Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4419391
[No Abstract] [Full Text] [Related]
5. Immunosuppression and oncogenic virus infections.
Hirsch MS; Black PH; Proffitt MR
Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
[No Abstract] [Full Text] [Related]
6. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
Purtilo DT
Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
[No Abstract] [Full Text] [Related]
7. Cancer in immunosuppressed experimental animals and human patients.
Allison AC
Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940
[No Abstract] [Full Text] [Related]
8. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
Hersh EM
Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
[No Abstract] [Full Text] [Related]
9. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Gleichmann E; Gleichmann H
Klin Wochenschr; 1973 Mar; 51(6):260-5 concl. PubMed ID: 4144595
[No Abstract] [Full Text] [Related]
11. Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.
Purtilo DT
Semin Oncol; 1977 Sep; 4(3):335-43. PubMed ID: 21454
[No Abstract] [Full Text] [Related]
12. Immunodepression and malignancy.
Stutman O
Adv Cancer Res; 1975; 22():261-422. PubMed ID: 766581
[No Abstract] [Full Text] [Related]
13. Immunologic interreactions in neoplastic diseases. A brief review.
Kushnick T
Clin Pediatr (Phila); 1971 Jul; 10(7):372-6. PubMed ID: 4933466
[No Abstract] [Full Text] [Related]
14. [Principal immunologic factors in carcinogenesis].
Melki G
Cah Med; 1973 Oct; 14(10):821-37. PubMed ID: 4806157
[No Abstract] [Full Text] [Related]
15. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
16. [Current immunologic data on Hodgkin's disease].
Weisgerber C; Kourilsky FM
Rev Prat; 1974 Oct; 24(45):3927-9. PubMed ID: 4445766
[No Abstract] [Full Text] [Related]
17. Contemporary immunologic considerations in head and neck tumors.
Berlinger NT; Good RA
Otolaryngol Clin North Am; 1974 Oct; 7(3):859-83. PubMed ID: 4607983
[No Abstract] [Full Text] [Related]
18. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
Chappuis BB; Müller-Hermelink HK
Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.
Swerdlow AJ
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S3-12. PubMed ID: 12734687
[TBL] [Abstract][Full Text] [Related]
20. Immunity and immunopathology in virus infections.
Allison AC
Ann Inst Pasteur (Paris); 1972 Oct; 123(4):585-608. PubMed ID: 4348598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
